Incidental Mutation 'R0784:Cbfa2t3'
ID 76776
Institutional Source Beutler Lab
Gene Symbol Cbfa2t3
Ensembl Gene ENSMUSG00000006362
Gene Name CBFA2/RUNX1 translocation partner 3
Synonyms MTGR2, A630044F12Rik, ETO-2, Eto2
MMRRC Submission 038964-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R0784 (G1)
Quality Score 167
Status Validated
Chromosome 8
Chromosomal Location 123351880-123425848 bp(-) (GRCm39)
Type of Mutation splice site
DNA Base Change (assembly) A to G at 123377226 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change
Ref Sequence ENSEMBL: ENSMUSP00000117630 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000006525] [ENSMUST00000064674] [ENSMUST00000127664] [ENSMUST00000127984] [ENSMUST00000134045]
AlphaFold no structure available at present
Predicted Effect probably benign
Transcript: ENSMUST00000006525
SMART Domains Protein: ENSMUSP00000006525
Gene: ENSMUSG00000006362

DomainStartEndE-ValueType
low complexity region 12 27 N/A INTRINSIC
TAFH 87 177 5.46e-52 SMART
low complexity region 248 257 N/A INTRINSIC
Pfam:NHR2 295 361 3.6e-41 PFAM
PDB:2KYG|C 395 424 3e-10 PDB
Pfam:zf-MYND 472 508 2.6e-10 PFAM
low complexity region 529 552 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000064674
SMART Domains Protein: ENSMUSP00000065728
Gene: ENSMUSG00000006362

DomainStartEndE-ValueType
low complexity region 12 27 N/A INTRINSIC
TAFH 113 203 5.46e-52 SMART
low complexity region 274 283 N/A INTRINSIC
Pfam:NHR2 321 387 7.1e-41 PFAM
PDB:2KYG|C 421 450 1e-10 PDB
Pfam:zf-MYND 498 534 7.1e-10 PFAM
low complexity region 555 578 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000127664
SMART Domains Protein: ENSMUSP00000118564
Gene: ENSMUSG00000092329

DomainStartEndE-ValueType
Pfam:Glycos_transf_2 104 287 7.4e-31 PFAM
Pfam:Glyco_transf_7C 261 331 4.9e-8 PFAM
RICIN 406 531 9.28e-27 SMART
Predicted Effect probably benign
Transcript: ENSMUST00000127984
SMART Domains Protein: ENSMUSP00000118997
Gene: ENSMUSG00000006362

DomainStartEndE-ValueType
low complexity region 47 62 N/A INTRINSIC
TAFH 148 238 5.46e-52 SMART
low complexity region 309 318 N/A INTRINSIC
Pfam:NHR2 356 422 2.3e-38 PFAM
PDB:2KYG|C 456 485 2e-10 PDB
Pfam:zf-MYND 533 569 6.9e-10 PFAM
low complexity region 590 613 N/A INTRINSIC
Predicted Effect probably benign
Transcript: ENSMUST00000134045
SMART Domains Protein: ENSMUSP00000117630
Gene: ENSMUSG00000006362

DomainStartEndE-ValueType
low complexity region 12 27 N/A INTRINSIC
Pfam:TAFH 111 185 3.7e-33 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000142535
Predicted Effect noncoding transcript
Transcript: ENSMUST00000147374
Predicted Effect noncoding transcript
Transcript: ENSMUST00000148630
Meta Mutation Damage Score 0.0898 question?
Coding Region Coverage
  • 1x: 99.6%
  • 3x: 98.9%
  • 10x: 96.9%
  • 20x: 92.1%
Validation Efficiency 97% (59/61)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the myeloid translocation gene family which interact with DNA-bound transcription factors and recruit a range of corepressors to facilitate transcriptional repression. The t(16;21)(q24;q22) translocation is one of the less common karyotypic abnormalities in acute myeloid leukemia. The translocation produces a chimeric gene made up of the 5'-region of the runt-related transcription factor 1 gene fused to the 3'-region of this gene. This gene is also a putative breast tumor suppressor. Alternative splicing results in transcript variants. [provided by RefSeq, Nov 2010]
PHENOTYPE: Mice that are homozygote null for this gene display skewing of the early myeloid progenitor cells toward the granulocytic/macrophage lineage while reducing the numbers of megakaryocyte-erythroid progenitor cells. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 58 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Acin1 T C 14: 54,890,985 (GRCm39) probably benign Het
Adamts2 C T 11: 50,558,830 (GRCm39) R182W probably damaging Het
Ahr C T 12: 35,558,141 (GRCm39) G293D possibly damaging Het
Akna G T 4: 63,295,125 (GRCm39) T1028K probably benign Het
Akp3 G A 1: 87,055,593 (GRCm39) G547R unknown Het
Aoc1l3 T A 6: 48,964,235 (GRCm39) M81K possibly damaging Het
Asic2 T A 11: 80,784,815 (GRCm39) M324L possibly damaging Het
Atf6 A G 1: 170,537,516 (GRCm39) F635L probably benign Het
Atp8b2 A T 3: 89,864,380 (GRCm39) V195E probably damaging Het
Bicd1 T A 6: 149,414,861 (GRCm39) C525S probably damaging Het
Cd46 G A 1: 194,774,502 (GRCm39) T11M possibly damaging Het
Cecr2 A G 6: 120,735,110 (GRCm39) H754R possibly damaging Het
Clcn3 G T 8: 61,382,237 (GRCm39) D450E probably benign Het
Cobl T G 11: 12,216,843 (GRCm39) probably benign Het
Cyba T A 8: 123,154,422 (GRCm39) T34S probably benign Het
Dennd1a A G 2: 37,911,426 (GRCm39) L187P probably damaging Het
Dennd4c A T 4: 86,763,145 (GRCm39) Q1817L probably benign Het
Drosha T C 15: 12,867,764 (GRCm39) probably benign Het
Dync1li2 A G 8: 105,169,130 (GRCm39) S34P probably damaging Het
Emilin2 T A 17: 71,582,282 (GRCm39) D148V possibly damaging Het
Galnt11 A G 5: 25,463,907 (GRCm39) D393G probably damaging Het
Gm5435 T A 12: 82,542,954 (GRCm39) noncoding transcript Het
Gpr176 C T 2: 118,203,533 (GRCm39) V46M possibly damaging Het
Gpr85 T A 6: 13,836,748 (GRCm39) H52L probably benign Het
Grn T C 11: 102,325,328 (GRCm39) M246T possibly damaging Het
Hnrnpul2 T C 19: 8,802,416 (GRCm39) F428L possibly damaging Het
Hoxa13 G C 6: 52,236,917 (GRCm39) N278K probably damaging Het
Irx5 A G 8: 93,087,118 (GRCm39) D350G probably benign Het
Kat2a C T 11: 100,601,667 (GRCm39) M249I probably benign Het
Klhl29 T C 12: 5,131,251 (GRCm39) Y782C probably damaging Het
Kmt2c A T 5: 25,515,893 (GRCm39) F2650Y probably benign Het
Lrp2 A G 2: 69,348,709 (GRCm39) I754T probably benign Het
LTO1 A T 7: 144,473,014 (GRCm39) Y108F probably benign Het
Mpl G A 4: 118,303,603 (GRCm39) P472S possibly damaging Het
Mtnr1b A G 9: 15,774,081 (GRCm39) I326T probably benign Het
Myh9 A G 15: 77,661,209 (GRCm39) probably benign Het
Mylk G C 16: 34,699,845 (GRCm39) E403Q possibly damaging Het
Myo9a A G 9: 59,803,828 (GRCm39) probably benign Het
Or2z2 T A 11: 58,346,131 (GRCm39) I215F possibly damaging Het
Or4ac1-ps1 T A 2: 88,370,511 (GRCm39) noncoding transcript Het
Pcsk5 T C 19: 17,692,133 (GRCm39) M184V probably benign Het
Piezo2 T A 18: 63,216,306 (GRCm39) D1143V probably damaging Het
Prr36 G T 8: 4,263,771 (GRCm39) probably benign Het
Rnf220 C A 4: 117,135,195 (GRCm39) probably benign Het
Senp3 A G 11: 69,571,274 (GRCm39) L131P probably damaging Het
Shc4 A C 2: 125,499,416 (GRCm39) W354G probably benign Het
Slc6a15 A G 10: 103,252,661 (GRCm39) probably benign Het
Smtnl2 T C 11: 72,290,763 (GRCm39) D394G probably damaging Het
Sry G T Y: 2,662,731 (GRCm39) Q310K unknown Het
St7l A G 3: 104,778,240 (GRCm39) M126V probably benign Het
St8sia3 T C 18: 64,404,772 (GRCm39) W350R probably damaging Het
Stk35 A T 2: 129,652,722 (GRCm39) K408* probably null Het
Thsd7b T C 1: 129,523,096 (GRCm39) probably benign Het
Tmem106b T C 6: 13,084,252 (GRCm39) V252A probably damaging Het
Trpm7 A G 2: 126,687,992 (GRCm39) probably null Het
Ttf2 T C 3: 100,870,026 (GRCm39) D349G probably benign Het
Zfp386 T A 12: 116,023,540 (GRCm39) C419* probably null Het
Zfp541 A G 7: 15,816,917 (GRCm39) probably benign Het
Other mutations in Cbfa2t3
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL02095:Cbfa2t3 APN 8 123,360,232 (GRCm39) missense probably damaging 1.00
IGL02578:Cbfa2t3 APN 8 123,360,187 (GRCm39) missense possibly damaging 0.83
IGL02934:Cbfa2t3 APN 8 123,374,497 (GRCm39) missense probably benign 0.03
IGL03089:Cbfa2t3 APN 8 123,361,873 (GRCm39) missense probably damaging 1.00
R0196:Cbfa2t3 UTSW 8 123,360,076 (GRCm39) missense possibly damaging 0.77
R0365:Cbfa2t3 UTSW 8 123,361,799 (GRCm39) missense probably benign 0.23
R0395:Cbfa2t3 UTSW 8 123,365,690 (GRCm39) missense probably benign 0.09
R0835:Cbfa2t3 UTSW 8 123,374,517 (GRCm39) missense probably benign 0.00
R1608:Cbfa2t3 UTSW 8 123,374,448 (GRCm39) missense probably damaging 0.99
R2008:Cbfa2t3 UTSW 8 123,370,032 (GRCm39) missense probably damaging 0.99
R2088:Cbfa2t3 UTSW 8 123,364,725 (GRCm39) unclassified probably benign
R2095:Cbfa2t3 UTSW 8 123,361,727 (GRCm39) missense probably benign
R4079:Cbfa2t3 UTSW 8 123,374,434 (GRCm39) splice site probably null
R4175:Cbfa2t3 UTSW 8 123,370,057 (GRCm39) missense probably damaging 1.00
R5013:Cbfa2t3 UTSW 8 123,365,598 (GRCm39) missense possibly damaging 0.95
R5141:Cbfa2t3 UTSW 8 123,361,760 (GRCm39) missense probably benign 0.24
R5391:Cbfa2t3 UTSW 8 123,360,134 (GRCm39) nonsense probably null
R6067:Cbfa2t3 UTSW 8 123,370,236 (GRCm39) missense probably benign 0.00
R6078:Cbfa2t3 UTSW 8 123,370,236 (GRCm39) missense probably benign 0.00
R6192:Cbfa2t3 UTSW 8 123,361,135 (GRCm39) missense probably benign 0.00
R6281:Cbfa2t3 UTSW 8 123,360,148 (GRCm39) missense probably damaging 1.00
R6520:Cbfa2t3 UTSW 8 123,362,540 (GRCm39) missense probably benign 0.02
R6936:Cbfa2t3 UTSW 8 123,374,478 (GRCm39) missense probably damaging 0.97
R7154:Cbfa2t3 UTSW 8 123,364,883 (GRCm39) nonsense probably null
R7196:Cbfa2t3 UTSW 8 123,365,729 (GRCm39) missense probably benign 0.26
R7295:Cbfa2t3 UTSW 8 123,364,768 (GRCm39) missense probably benign 0.02
R7514:Cbfa2t3 UTSW 8 123,361,865 (GRCm39) missense probably damaging 1.00
R7616:Cbfa2t3 UTSW 8 123,360,076 (GRCm39) missense possibly damaging 0.87
R8070:Cbfa2t3 UTSW 8 123,369,720 (GRCm39) missense possibly damaging 0.81
R8485:Cbfa2t3 UTSW 8 123,357,517 (GRCm39) missense probably damaging 0.97
R8534:Cbfa2t3 UTSW 8 123,365,653 (GRCm39) missense probably damaging 1.00
R9718:Cbfa2t3 UTSW 8 123,364,936 (GRCm39) missense probably benign 0.25
U15987:Cbfa2t3 UTSW 8 123,370,236 (GRCm39) missense probably benign 0.00
Z1176:Cbfa2t3 UTSW 8 123,425,634 (GRCm39) start gained probably benign
Z1177:Cbfa2t3 UTSW 8 123,357,496 (GRCm39) missense probably benign
Predicted Primers PCR Primer
(F):5'- TTCTACACAAGGTATGGGCAGGGG -3'
(R):5'- TCACTCGGACATGCTTGGTAATGG -3'

Sequencing Primer
(F):5'- GTCGTGGGCAGGGAGAC -3'
(R):5'- TTAGATGCCACCTGTGAGAAC -3'
Posted On 2013-10-16